Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer?s products are justly used in local region or countries.
This report contains market size and forecasts of Human Fibrinogen in global, including the following market information:
Global Human Fibrinogen Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Fibrinogen Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Human Fibrinogen companies in 2021 (%)
The global Human Fibrinogen market was valued at 818.8 million in 2021 and is projected to reach US$ 2156.1 million by 2028, at a CAGR of 14.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Human Fibrinogen Concentrate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Fibrinogen include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical and Octapharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Fibrinogen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Fibrinogen Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Human Fibrinogen Market Segment Percentages, by Type, 2021 (%)
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate
Global Human Fibrinogen Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Human Fibrinogen Market Segment Percentages, by Application, 2021 (%)
Congenital Fibrinogen Deficiency
Surgical Procedures
Global Human Fibrinogen Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Human Fibrinogen Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Fibrinogen revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Fibrinogen revenues share in global market, 2021 (%)
Key companies Human Fibrinogen sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Human Fibrinogen sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma

LEAVE A REPLY

Please enter your comment!
Please enter your name here